Somatus is a provider of value-based kidney care, offering vertically integrated clinical services and technology designed to delay or prevent disease progression, improve quality and care coordination, and increase the use of home dialysis modalities and rates of kidney transplantation.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
06/29/2023 | Series FNV | $50MM | $xx.xx | $3.53B | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
45,197
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
06/29/2023 | Series F | $200MM | $xx.xx | $3.53B | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
180,788
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
02/23/2022 | Series E | $325MM | $xx.xx | $2.5B | Anthem, Blue Venture Fund, Deerfield Management Company, Fidelity, Flare Capital Partners, Gic, Inova Health System, Longitude Capital, Optum Ventures, Ra Capital Management, Wellington Management | |
Price per Share
$xx.xx
Shares Outstanding
372,435
Liquidation Pref Order
2
Liquidation Pref As Multiplier
2.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Anthem, Blue Venture Fund, Deerfield Management Company, Fidelity, Flare Capital Partners, Gic, Inova Health System, Longitude Capital, Optum Ventures, Ra Capital Management, Wellington Management
|
||||||
06/16/2021 | Series D | $60.12MM | $xx.xx | $548.53MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
294,374
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
06/23/2020 | Series C-3 | $5.38MM | $xx.xx | $235.94MM | Blue Venture Fund, Deerfield Management Company, Flare Capital, Longitude Capital, Optum Ventures, Town Hall Ventures | |
Price per Share
$xx.xx
Shares Outstanding
131,316
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Blue Venture Fund, Deerfield Management Company, Flare Capital, Longitude Capital, Optum Ventures, Town Hall Ventures
|
||||||
06/23/2020 | Series C-2 | $7.2MM | $xx.xx | $235.94MM | Blue Venture Fund, Deerfield Management Company, Flare Capital, Longitude Capital, Optum Ventures, Town Hall Ventures | |
Price per Share
$xx.xx
Shares Outstanding
86,767
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Blue Venture Fund, Deerfield Management Company, Flare Capital, Longitude Capital, Optum Ventures, Town Hall Ventures
|
||||||
06/23/2020 | Series C-1 | $64MM | $xx.xx | $235.94MM | Blue Venture Fund, Deerfield Management Company, Flare Capital, Longitude Capital, Optum Ventures, Town Hall Ventures | |
Price per Share
$xx.xx
Shares Outstanding
617,091
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Blue Venture Fund, Deerfield Management Company, Flare Capital, Longitude Capital, Optum Ventures, Town Hall Ventures
|
||||||
04/11/2018 | Series B | $11.5MM | $xx.xx | $48.43MM | Bluecross Blueshield Venture Partners, Flare Capital Partners, Inova Health System | |
Price per Share
$xx.xx
Shares Outstanding
314,583
Liquidation Pref Order
4
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Bluecross Blueshield Venture Partners, Flare Capital Partners, Inova Health System
|
||||||
04/20/2017 | Series A | $3.18MM | $xx.xx | $16.67MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
136,847
Liquidation Pref Order
4
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|